Enrique A. Conterno - Mar 8, 2023 Form 4/A - Amendment Insider Report for FIBROGEN INC (FGEN)

Role
Chief Executive Officer, Director
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Stock symbol
FGEN
Transactions as of
Mar 8, 2023
Transactions value $
-$393,625
Form type
4/A - Amendment
Date filed
3/23/2023, 04:50 PM
Date Of Original Report
Mar 10, 2023
Previous filing
Feb 23, 2023
Next filing
Apr 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Sale -$394K -19.5K -4.82% $20.20* 385K Mar 10, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I.

Remarks:

This From 4/A is being filed to correct the number of shares sold in column 4.